Clinical Biochemistry and Metabolism - Issue 2/2013
71
The role of bone metabolism parameters in the assessment of myeloma bone disease
V. Ščudla, P. Petrová, P. Lochman, J. Minařík, T. Pika, J. Bačovský
79
The importance of selected laboratory parameters for the diagnostics, stratification and monitoring of AL amyloidosis patients
T. Pika, P. Lochman, P. Flodr, J. Minařík, P. Látalová, J. Bačovský, V. Ščudla
83
Clinical and laboratory aspects of biclonal gammopathy of undetermined significance - BGUS
T. Pika, P. Lochman, V. Maisnar, M. Tichý, J. Minařík, R. Hájek, V. Ščudla
88
Haemodialysis using high cut-off dialysers in acute kidney injury in multiple myeloma – first experience
J. Orság, T. Pika, Z. Kosatíková, P. Lochman, K. Žamboch, J. Minařík, M. Hrubý, V. Ščudla, J. Zadražil
93
97
103
Significant decrease of blood lead levels in lead-exposed workers due to effective preventive measures
F. Los, L. Kotackova, T. Zima
Clinical Biochemistry and Metabolism
2013 Číslo 2
Najčítanejšie v tomto čísle
- Clinical and laboratory aspects of biclonal gammopathy of undetermined significance - BGUS
- The role of bone metabolism parameters in the assessment of myeloma bone disease
- Significant decrease of blood lead levels in lead-exposed workers due to effective preventive measures
- The risk of transformation in monoclonal gammopathy of undetermined significance in malignant monoclonal gammopathy